ARTICLE | Company News
Inverness, Blanchette Rockefeller Neurosciences Institute deal
June 8, 2009 7:00 AM UTC
Inverness received an option to license worldwide rights to the institute's technology covering its undisclosed Alzheimer's disease biomarker to diagnose and predict disease progression and monitor tr...